Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Retinal gene therapy is a treatment approach that aims to restore or replace the faulty or missing genes that cause inherited retinal diseases. Inherited retinal diseases like Retinitis Pigmentosa or Leber Congenital Amaurosis occur due to a genetic mutation that leads to the degeneration of photoreceptor cells in the retina, ultimately leading to vision loss or blindness. However, this treatment is still in the early stages of development and is not yet available as a standard treatment.
The report details the trend, potential and market size of Retinal Gene Therapy market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Retinal Gene Therapymarket, defines the market attractiveness level of Retinal Gene Therapy market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Retinal Gene Therapy industry, describes the types of Retinal Gene Therapy market, the applications of major players and the market size, and deeply analyzes the current situation of the global Retinal Gene Therapy market and the development prospects and opportunities of Retinal Gene Therapy industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Retinal Gene Therapy market in Chapter 13.
By Player:
Adverum Biotechnologies
MeiraGTx Holdings plc
Second Sight Medical Products
Nightstar Therapeutics
Adverio Pharmaceuticals
Biogen Inc
REGENXBIO Inc
Applied Genetic Technologies Corporation (AGTC)
Gyroscope Therapeutics (Novartis)
Hemera Biosciences
Oxford Biomedica
GenSight Biologics
By Type:
Others
Leber Congenital Amaurosis (LCA)
X-linked Retinitis Pigmentosa (RP)
Choroideremia
Stargardt Disease
By End-User:
Hospitals
Academic & Research Institutes
Others
Ophthalmic Clinics
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Retinal Gene Therapy Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Retinal Gene Therapy Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Retinal Gene Therapy Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Retinal Gene Therapy Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Retinal Gene Therapy Market Analysis and Outlook to 2022
-
7.1 Global Retinal Gene Therapy Consumption (2017-2022)
-
7.2 United States Retinal Gene Therapy Consumption (2017-2022)
-
7.3 Europe Retinal Gene Therapy Consumption (2017-2022)
-
7.4 China Retinal Gene Therapy Consumption (2017-2022)
-
7.5 Japan Retinal Gene Therapy Consumption (2017-2022)
-
7.6 India Retinal Gene Therapy Consumption (2017-2022)
-
7.7 South Korea Retinal Gene Therapy Consumption (2017-2022)
8 Region and Country-wise Retinal Gene Therapy Market Analysis and Outlook to 2028
-
8.1 Global Retinal Gene Therapy Consumption Forecast (2022-2028)
-
8.2 United States Retinal Gene Therapy Consumption Forecast (2022-2028)
-
8.3 Europe Retinal Gene Therapy Consumption Forecast (2022-2028)
-
8.4 China Retinal Gene Therapy Consumption Forecast (2022-2028)
-
8.5 Japan Retinal Gene Therapy Consumption Forecast (2022-2028)
-
8.6 India Retinal Gene Therapy Consumption Forecast (2022-2028)
-
8.7 South Korea Retinal Gene Therapy Consumption Forecast (2022-2028)
9 Global Retinal Gene Therapy Market Outlook by Types and Applications to 2022
-
9.1 Global Retinal Gene Therapy Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Others Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Leber Congenital Amaurosis (LCA) Consumption and Growth Rate (2017-2022)
-
9.1.3 Global X-linked Retinitis Pigmentosa (RP) Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Choroideremia Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Stargardt Disease Consumption and Growth Rate (2017-2022)
-
9.2 Global Retinal Gene Therapy Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Academic & Research Institutes Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Ophthalmic Clinics Consumption and Growth Rate (2017-2022)
10 Global Retinal Gene Therapy Market Outlook by Types and Applications to 2028
-
10.1 Global Retinal Gene Therapy Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Leber Congenital Amaurosis (LCA) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global X-linked Retinitis Pigmentosa (RP) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Choroideremia Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Stargardt Disease Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Retinal Gene Therapy Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Academic & Research Institutes Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Ophthalmic Clinics Consumption Forecast and Growth Rate (2022-2028)
11 Global Retinal Gene Therapy Import and Export Analysis (Top 5 Countries)
-
11.1 Global Retinal Gene Therapy Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Retinal Gene Therapy Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Retinal Gene Therapy Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Retinal Gene Therapy Market Competitive Analysis
-
14.1 Adverum Biotechnologies
-
14.1.1 Adverum Biotechnologies Company Details
-
14.1.2 Adverum Biotechnologies Retinal Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Adverum Biotechnologies Retinal Gene Therapy Product and Service
-
14.2 MeiraGTx Holdings plc
-
14.2.1 MeiraGTx Holdings plc Company Details
-
14.2.2 MeiraGTx Holdings plc Retinal Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 MeiraGTx Holdings plc Retinal Gene Therapy Product and Service
-
14.3 Second Sight Medical Products
-
14.3.1 Second Sight Medical Products Company Details
-
14.3.2 Second Sight Medical Products Retinal Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Second Sight Medical Products Retinal Gene Therapy Product and Service
-
14.4 Nightstar Therapeutics
-
14.4.1 Nightstar Therapeutics Company Details
-
14.4.2 Nightstar Therapeutics Retinal Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Nightstar Therapeutics Retinal Gene Therapy Product and Service
-
14.5 Adverio Pharmaceuticals
-
14.5.1 Adverio Pharmaceuticals Company Details
-
14.5.2 Adverio Pharmaceuticals Retinal Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Adverio Pharmaceuticals Retinal Gene Therapy Product and Service
-
14.6 Biogen Inc
-
14.6.1 Biogen Inc Company Details
-
14.6.2 Biogen Inc Retinal Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Biogen Inc Retinal Gene Therapy Product and Service
-
14.7 REGENXBIO Inc
-
14.7.1 REGENXBIO Inc Company Details
-
14.7.2 REGENXBIO Inc Retinal Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 REGENXBIO Inc Retinal Gene Therapy Product and Service
-
14.8 Applied Genetic Technologies Corporation (AGTC)
-
14.8.1 Applied Genetic Technologies Corporation (AGTC) Company Details
-
14.8.2 Applied Genetic Technologies Corporation (AGTC) Retinal Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Applied Genetic Technologies Corporation (AGTC) Retinal Gene Therapy Product and Service
-
14.9 Gyroscope Therapeutics (Novartis)
-
14.9.1 Gyroscope Therapeutics (Novartis) Company Details
-
14.9.2 Gyroscope Therapeutics (Novartis) Retinal Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Gyroscope Therapeutics (Novartis) Retinal Gene Therapy Product and Service
-
14.10 Hemera Biosciences
-
14.10.1 Hemera Biosciences Company Details
-
14.10.2 Hemera Biosciences Retinal Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Hemera Biosciences Retinal Gene Therapy Product and Service
-
14.11 Oxford Biomedica
-
14.11.1 Oxford Biomedica Company Details
-
14.11.2 Oxford Biomedica Retinal Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Oxford Biomedica Retinal Gene Therapy Product and Service
-
14.12 GenSight Biologics
-
14.12.1 GenSight Biologics Company Details
-
14.12.2 GenSight Biologics Retinal Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 GenSight Biologics Retinal Gene Therapy Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Retinal Gene Therapy
-
Figure Retinal Gene Therapy Picture
-
Table Global Retinal Gene Therapy Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Retinal Gene Therapy Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Retinal Gene Therapy Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Retinal Gene Therapy Consumption by Country (2017-2022)
-
Figure United States Retinal Gene Therapy Consumption and Growth Rate (2017-2022)
-
Table Europe Retinal Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure China Retinal Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Japan Retinal Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure India Retinal Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure South Korea Retinal Gene Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Retinal Gene Therapy Consumption Forecast by Country (2022-2028)
-
Figure United States Retinal Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Retinal Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Retinal Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Retinal Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Retinal Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Retinal Gene Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Leber Congenital Amaurosis (LCA) Consumption and Growth Rate (2017-2022)
-
Figure Global X-linked Retinitis Pigmentosa (RP) Consumption and Growth Rate (2017-2022)
-
Figure Global Choroideremia Consumption and Growth Rate (2017-2022)
-
Figure Global Stargardt Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Academic & Research Institutes Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Ophthalmic Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Leber Congenital Amaurosis (LCA) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global X-linked Retinitis Pigmentosa (RP) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Choroideremia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Stargardt Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Academic & Research Institutes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ophthalmic Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Retinal Gene Therapy Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Retinal Gene Therapy Export by Region (Top 5 Countries) (2017-2028)
-
Table Adverum Biotechnologies (Foundation Year, Company Profile and etc.)
-
Table Adverum Biotechnologies Retinal Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Adverum Biotechnologies Retinal Gene Therapy Product and Service
-
Table MeiraGTx Holdings plc (Foundation Year, Company Profile and etc.)
-
Table MeiraGTx Holdings plc Retinal Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table MeiraGTx Holdings plc Retinal Gene Therapy Product and Service
-
Table Second Sight Medical Products (Foundation Year, Company Profile and etc.)
-
Table Second Sight Medical Products Retinal Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Second Sight Medical Products Retinal Gene Therapy Product and Service
-
Table Nightstar Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Nightstar Therapeutics Retinal Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nightstar Therapeutics Retinal Gene Therapy Product and Service
-
Table Adverio Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Adverio Pharmaceuticals Retinal Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Adverio Pharmaceuticals Retinal Gene Therapy Product and Service
-
Table Biogen Inc (Foundation Year, Company Profile and etc.)
-
Table Biogen Inc Retinal Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Inc Retinal Gene Therapy Product and Service
-
Table REGENXBIO Inc (Foundation Year, Company Profile and etc.)
-
Table REGENXBIO Inc Retinal Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table REGENXBIO Inc Retinal Gene Therapy Product and Service
-
Table Applied Genetic Technologies Corporation (AGTC) (Foundation Year, Company Profile and etc.)
-
Table Applied Genetic Technologies Corporation (AGTC) Retinal Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Applied Genetic Technologies Corporation (AGTC) Retinal Gene Therapy Product and Service
-
Table Gyroscope Therapeutics (Novartis) (Foundation Year, Company Profile and etc.)
-
Table Gyroscope Therapeutics (Novartis) Retinal Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gyroscope Therapeutics (Novartis) Retinal Gene Therapy Product and Service
-
Table Hemera Biosciences (Foundation Year, Company Profile and etc.)
-
Table Hemera Biosciences Retinal Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hemera Biosciences Retinal Gene Therapy Product and Service
-
Table Oxford Biomedica (Foundation Year, Company Profile and etc.)
-
Table Oxford Biomedica Retinal Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Oxford Biomedica Retinal Gene Therapy Product and Service
-
Table GenSight Biologics (Foundation Year, Company Profile and etc.)
-
Table GenSight Biologics Retinal Gene Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table GenSight Biologics Retinal Gene Therapy Product and Service
-
